Dasatinib belongs to a group of anti-cancer drugs commonly used to treat certain cancers, such as chronic granulomatous leukemia, acute lymphoblastic leukemia, when other cancer treatments are not effective. Dasatinib has the ability to inhibit tyrosine kinase to help slow or stop the growth of cancer cells.